Page last updated: 2024-08-18

arginine vasopressin and Prostatic Neoplasms, Castration-Resistant

arginine vasopressin has been researched along with Prostatic Neoplasms, Castration-Resistant in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Burnstein, KL; Copello, VA; Heidman, LM; Peinetti, N1

Other Studies

1 other study(ies) available for arginine vasopressin and Prostatic Neoplasms, Castration-Resistant

ArticleYear
Exploiting Dependence of Castration-Resistant Prostate Cancer on the Arginine Vasopressin Signaling Axis by Repurposing Vaptans.
    Molecular cancer research : MCR, 2022, 08-05, Volume: 20, Issue:8

    Topics: Androgen Antagonists; Arginine Vasopressin; Cell Line, Tumor; Humans; Male; Neoplasm Recurrence, Local; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen; Receptors, Vasopressin

2022